Generic placeholder image

Pharmaceutical Nanotechnology

Editor-in-Chief

ISSN (Print): 2211-7385
ISSN (Online): 2211-7393

Review Article

SEDDS Basic Design and Recent Formulation Advancement: A Concurrent Review

Author(s): K.C. Panigrahi*, C.N. Patra, M.E.B. Rao, G.K. Jena and L. Sahoo

Volume 10, Issue 4, 2022

Published on: 06 October, 2022

Page: [289 - 298] Pages: 10

DOI: 10.2174/2211738510666220817124744

Price: $65

Abstract

In the present scenario, lipid-based novel drug delivery systems are the area of interest for the formulation scientist in order to improve the bioavailability of poorly water-soluble drugs. A selfemulsifying drug delivery system (SEDDS) upon contact with the gastrointestinal fluid, forms an o/w emulsion. SEDDS has gained popularity as a potential platform for improving the bioavailability of the lipophilic drug by overcoming several challenges. The various advantages like improved solubility, bypassing lymphatic transport, and improvement in bioavailability are associated with SMEDDS or SNEDDS. The extent of the formation of stable SEDDS depends on a specific combination of surfactant, co-surfactant, and oil. The present review highlighted the different aspects of formulation design along with optimization and characterization of SEDDS formulation. It also gives a brief description of the various aspects of the excipients used in SEDDS formulation. This review also includes the conflict between types of SEDDS based on droplet size. There is an extensive review of various research regarding different solidification techniques used for SEDDS in the last three years.

Keywords: Lipid formulation classification system, Pseudo-ternary, Quality by Design, Supersaturation, Spray Drying

Graphical Abstract

[1]
Singh B, Bandopadhyay S, Kapil R, Singh R, Katare O. Self-emulsifying drug delivery systems (SEDDS): Formulation development, characterization, and applications. Crit Rev Ther Drug Carrier Syst 2009; 26(5): 427-521.
[http://dx.doi.org/10.1615/CritRevTherDrugCarrierSyst.v26.i5.10] [PMID: 20136631]
[2]
Pouton CW. Formulation of self-emulsifying drug delivery systems. Adv Drug Deliv Rev 1997; 25(1): 47-58.
[http://dx.doi.org/10.1016/S0169-409X(96)00490-5]
[3]
Pouton CW, Porter CJH. Formulation of lipid-based delivery systems for oral administration: Materials, methods and strategies. Adv Drug Deliv Rev 2008; 60(6): 625-37.
[http://dx.doi.org/10.1016/j.addr.2007.10.010] [PMID: 18068260]
[4]
Humberstone AJ, Charman WN. Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv Drug Deliv Rev 1997; 25(1): 103-28.
[http://dx.doi.org/10.1016/S0169-409X(96)00494-2]
[5]
Azeem A, Rizwan M, Ahmad FJ, et al. Nanoemulsion components screening and selection: A technical note. AAPS PharmSciTech 2009; 10(1): 69-76.
[http://dx.doi.org/10.1208/s12249-008-9178-x] [PMID: 19148761]
[6]
Pouton CW. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci 2006; 29(3-4): 278-87.
[http://dx.doi.org/10.1016/j.ejps.2006.04.016] [PMID: 16815001]
[7]
Chen ML. ML C. Lipid excipients and delivery systems for pharmaceutical development: A regulatory perspective. Adv Drug Deliv Rev 2008; 60(6): 768-77.
[http://dx.doi.org/10.1016/j.addr.2007.09.010] [PMID: 18077051]
[8]
Shah NH, Carvajal MT, Patel CI, Infeld MH, Malick AW. Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int J Pharm 1994; 106(1): 15-23.
[http://dx.doi.org/10.1016/0378-5173(94)90271-2]
[9]
Ofokansi KC, Chukwu KI, Ugwuanyi SI. The use of liquid self-microemulsifying drug delivery systems based on peanut oil/tween 80 in the delivery of griseofulvin. Drug Dev Ind Pharm 2009; 35(2): 185-91.
[http://dx.doi.org/10.1080/03639040802244292] [PMID: 18825525]
[10]
Li P, Ghosh A, Wagner RF, Krill S, Joshi YM, Serajuddin AT. Effect of combined use of nonionic surfactant on formation of oil-in-water microemulsions. Int J Pharm 2005; 288(1): 27-34.
[http://dx.doi.org/10.1016/j.ijpharm.2004.08.024] [PMID: 15607255]
[11]
Rang MJ, Miller CA. Spontaneous emulsification of oils containing hydrocarbon, nonionic surfactant, and oleyl alcohol. J Colloid Interface Sci 1999; 209(1): 179-92.
[http://dx.doi.org/10.1006/jcis.1998.5865] [PMID: 9878151]
[12]
Gershanik T, Benita S. Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur J Pharm Biopharm 2000; 50(1): 179-88.
[http://dx.doi.org/10.1016/S0939-6411(00)00089-8] [PMID: 10840200]
[13]
Barker SA, Yap SP, Yuen KH, McCoy CP, Murphy JR, Craig DQM. An investigation into the structure and bioavailability of α-tocopherol dispersions in Gelucire 44/14. J Control Release 2003; 91(3): 477-88.
[http://dx.doi.org/10.1016/S0168-3659(03)00261-X] [PMID: 12932724]
[14]
Kommuru TR, Gurley B, Khan MA, Reddy IK. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: Formulation development and bioavailability assessment. Int J Pharm 2001; 212(2): 233-46.
[http://dx.doi.org/10.1016/S0378-5173(00)00614-1] [PMID: 11165081]
[15]
Kale AA, Patravale VB. Design and evaluation of self-emulsifying drug delivery systems (SEDDS) of nimodipine. AAPS PharmSciTech 2008; 9(1): 191-6.
[http://dx.doi.org/10.1208/s12249-008-9037-9] [PMID: 18446481]
[16]
Borhade VB, Nair HA, Hegde DD. Development and characterization of self-microemulsifying drug delivery system of tacrolimus for intravenous administration. Drug Dev Ind Pharm 2009; 35(5): 619-30.
[http://dx.doi.org/10.1080/03639040802498856] [PMID: 18979309]
[17]
Balakrishnan P, Lee BJ, Oh DH, et al. Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems. Int J Pharm 2009; 374(1-2): 66-72.
[http://dx.doi.org/10.1016/j.ijpharm.2009.03.008] [PMID: 19446761]
[18]
Zhu JX, Tang D, Feng L, et al. Development of self-microemulsify-ing drug delivery system for oral bioavailability enhancement of berberine hydrochloride. Drug Dev Ind Pharm 2013; 39(3): 499-506.
[http://dx.doi.org/10.3109/03639045.2012.683875] [PMID: 22563917]
[19]
Bahloul B, Lassoued MA, Seguin J, et al. Self-emulsifying drug delivery system developed by the HLB-RSM approach: Characterization by transmission electron microscopy and pharmacokinetic study. Int J Pharm 2015; 487(1-2): 56-63.
[http://dx.doi.org/10.1016/j.ijpharm.2015.04.018] [PMID: 25870031]
[20]
Wu Z, Guo D, Deng L, Zhang Y, Yang Q, Chen J. Preparation and evaluation of a self-emulsifying drug delivery system of etoposide-phospholipid complex. Drug Dev Ind Pharm 2011; 37(1): 103-12.
[http://dx.doi.org/10.3109/03639045.2010.495752] [PMID: 21073324]
[21]
Ujhelyi Z, Vecsernyés M, Fehér P, et al. Physico-chemical characterization of self-emulsifying drug delivery systems. Drug Discov Today Technol 2018; 27: 81-6.
[http://dx.doi.org/10.1016/j.ddtec.2018.06.005] [PMID: 30103867]
[22]
Patel A, Shelat P, Lalwani A. Development and optimization of solid self nanoemulsifying drug delivery (S-SNEDDS) using D-optimal design for improvement of oral bioavailability of amiodarone hydrochloride. Curr Drug Deliv 2015; 12(6): 745-60.
[http://dx.doi.org/10.2174/1567201812666150302122501] [PMID: 25731867]
[23]
Ali HH, Hussein AA. Oral solid self-nanoemulsifying drug delivery systems of candesartan citexetil: Formulation, characterization and in vitro drug release studies. AAPS Open 2017; 3(1): 1-17.
[http://dx.doi.org/10.1186/s41120-017-0015-8]
[24]
Salem HF, Kharshoum RM, Halawa AKA, Naguib DM. Preparation and optimization of tablets containing a self-nano-emulsifying drug delivery system loaded with rosuvastatin. J Liposome Res 2018; 28(2): 149-60.
[http://dx.doi.org/10.1080/08982104.2017.1295990] [PMID: 28287014]
[25]
Mahmood A, Bernkop-Schnürch A. SEDDS: A game changing approach for the oral administration of hydrophilic macromolecular drugs. Adv Drug Deliv Rev 2019; 142: 91-101.
[http://dx.doi.org/10.1016/j.addr.2018.07.001] [PMID: 29981355]
[26]
Nardin I, Köllner S. Successful development of oral SEDDS: Screening of excipients from the industrial point of view. Adv Drug Deliv Rev 2019; 142: 128-40.
[http://dx.doi.org/10.1016/j.addr.2018.10.014] [PMID: 30414496]
[27]
Zaichik S, Steinbring C, Caliskan C, Bernkop-Schnürch A. Development and in vitro evaluation of a self-emulsifying drug delivery system (SEDDS) for oral vancomycin administration. Int J Pharm 2019; 554: 125-33.
[http://dx.doi.org/10.1016/j.ijpharm.2018.11.010] [PMID: 30408530]
[28]
Tran T, Rades T, Müllertz A. Formulation of self-nanoemulsifying drug delivery systems containing monoacyl phosphatidylcholine and Kolliphor® RH40 using experimental design. Asian J Pharm Sci 2018; 13(6): 536-45.
[http://dx.doi.org/10.1016/j.ajps.2017.09.006] [PMID: 32104428]
[29]
Soltani Y, Goodarzi N, Mahjub R. Preparation and characterization of self nano-emulsifying drug delivery system (SNEDDS) for oral delivery of heparin using hydrophobic complexation by cationic polymer of β-cyclodextrin. Drug Dev Ind Pharm 2017; 43(11): 1899-907.
[http://dx.doi.org/10.1080/03639045.2017.1353522] [PMID: 28685625]
[30]
Dhal C, Mishra R. Formulation development and in vitro evaluation of gentamicin sulfate-loaded PLGA nanoparticles based film for the treatment of surgical site infection by Box-Behnken design. Drug Dev Ind Pharm 2019; 45(5): 805-18.
[http://dx.doi.org/10.1080/03639045.2019.1576719] [PMID: 30698993]
[31]
Al-Nimry SS, Alkhamis KA, Altaani BM. Solid self-nanoemulsifying drug delivery system filled in enteric coated hard gelatin capsules for enhancing solubility and stability of omeprazole hydrochloride. Pharm Dev Technol 2020; 25(5): 588-600.
[http://dx.doi.org/10.1080/10837450.2020.1721536] [PMID: 31976799]
[32]
Fitria A, Hanifah S, Chabib L, et al. Design and characterization of propolis extract loaded self-nano emulsifying drug delivery system as immunostimulant. Saudi Pharm J 2021; 29(6): 625-34.
[http://dx.doi.org/10.1016/j.jsps.2021.04.024] [PMID: 34194270]
[33]
Chintalapudi R, Murthy TEGK, Lakshmi KR, Manohar GG. Formulation, optimization, and evaluation of self-emulsifying drug delivery systems of nevirapine. Int J Pharm Investig 2015; 5(4): 205-13.
[http://dx.doi.org/10.4103/2230-973X.167676] [PMID: 26682191]
[34]
Rohrer J, Partenhauser A, Hauptstein S, et al. Mucus permeating thiolated self-emulsifying drug delivery systems. Eur J Pharm Biopharm 2016; 98: 90-7.
[http://dx.doi.org/10.1016/j.ejpb.2015.11.004] [PMID: 26598209]
[35]
Taha EI, Al-Saidan S, Samy AM, Khan MA. Preparation and in vitro characterization of self-nanoemulsified drug delivery system (SNEDDS) of all-trans-retinol acetate. Int J Pharm 2004; 285(1-2): 109-19.
[http://dx.doi.org/10.1016/j.ijpharm.2004.03.034] [PMID: 15488684]
[36]
Dalal L, Allaf AW, El-Zein H. Formulation and in vitro evaluation of self-nanoemulsifying liquisolid tablets of furosemide. Sci Rep 2021; 11(1): 1315.
[http://dx.doi.org/10.1038/s41598-020-79940-5] [PMID: 33446749]
[37]
Yoo JH, Shanmugam S, Thapa P, et al. Novel self-nanoemulsifying drug delivery system for enhanced solubility and dissolution of lutein. Arch Pharm Res 2010; 33(3): 417-26.
[http://dx.doi.org/10.1007/s12272-010-0311-5] [PMID: 20361307]
[38]
Sampson A, Kenett RS. Statistical Aspects in ICH, FDA and EMA Guidelines Statistical Methods in Healthcare. John Wiley and Sons 2012; pp. 1-21.
[http://dx.doi.org/10.1002/9781119940012.ch1]
[39]
Van Buskirk GA, Asotra S, Balducci C, et al. Best practices for the development, scale-up, and post-approval change control of IR and MR dosage forms in the current quality-by-design paradigm. AAPS PharmSciTech 2014; 15(3): 665-93.
[http://dx.doi.org/10.1208/s12249-014-0087-x] [PMID: 24578237]
[40]
Silva BMA, Vicente S, Cunha S, et al. Retrospective Quality by Design (rQbD) applied to the optimization of orodispersible films. Int J Pharm 2017; 528(1-2): 655-63.
[http://dx.doi.org/10.1016/j.ijpharm.2017.06.054] [PMID: 28629981]
[41]
Zhang L, Mao S. Applications of quality by design (QbD) and its tools in drug delivery. Asian J Pharm Sci 2016; 11(1): 144-5.
[http://dx.doi.org/10.1016/j.ajps.2015.11.084]
[42]
Panigrahi KC, Jena J, Jena GK, Patra CN, Rao MEB. QBD-based systematic development of Bosentan SNEDDS: Formulation, characterization and pharmacokinetic assessment. J Drug Deliv Sci Technol 2018; 47: 31-42.
[http://dx.doi.org/10.1016/j.jddst.2018.06.021]
[43]
Garg B, Beg S, Kaur R, Kumar R, Katare OP, Singh B. Long-chain triglycerides-based self-nanoemulsifying oily formulations (SNEOFs) of darunavir with improved lymphatic targeting potential. J Drug Target 2018; 26(3): 252-66.
[http://dx.doi.org/10.1080/1061186X.2017.1365875] [PMID: 28805469]
[44]
Dalvadi H, Patel N, Parmar K. Systematic development of design of experiments (DoE) optimised self-microemulsifying drug delivery system of Zotepine. J Microencapsul 2017; 34(3): 308-18.
[http://dx.doi.org/10.1080/02652048.2017.1324920] [PMID: 28452252]
[45]
Gade MM, Hurkadale PJ. Formulation and evaluation of self-emulsifying orlistat tablet to enhance drug release and in vivo performance: Factorial design approach. Drug Deliv Transl Res 2016; 6(3): 276-88.
[http://dx.doi.org/10.1007/s13346-016-0289-8] [PMID: 27037924]
[46]
Beg S, Sandhu PS, Batra RS, Khurana RK, Singh B. QbD-based systematic development of novel optimized solid self-nanoemulsify-ing drug delivery systems (SNEDDS) of lovastatin with enhanced biopharmaceutical performance. Drug Deliv 2015; 22(6): 765-84.
[http://dx.doi.org/10.3109/10717544.2014.900154] [PMID: 24673611]
[47]
Rosso A, Almouazen E, Pontes J, et al. Supersaturable self-microemulsifying delivery systems: An approach to enhance oral bioavailability of benzimidazole anticancer drugs. Drug Deliv Transl Res 2021; 11(2): 675-91.
[http://dx.doi.org/10.1007/s13346-021-00904-x] [PMID: 33738676]
[48]
Zhang N, Zhang F, Xu S, Yun K, Wu W, Pan W. Formulation and evaluation of luteolin supersaturatable self-nanoemulsifying drug delivery system (S-SNEDDS) for enhanced oral bioavailability. J Drug Deliv Sci Technol 2020; 58: 101783.
[http://dx.doi.org/10.1016/j.jddst.2020.101783]
[49]
Sharma T, Jain A, Kaur R, Saini S, Katare OP, Singh B. Supersaturated LFCS type III self-emulsifying delivery systems of sorafenib tosylate with improved biopharmaceutical performance: QbD-enabled development and evaluation. Drug Deliv Transl Res 2020; 10(4): 839-61.
[http://dx.doi.org/10.1007/s13346-020-00772-x] [PMID: 32415654]
[50]
Panigrahi KC, Patra CN, Rao MEB. Quality by design enabled development of oral self-nanoemulsifying drug delivery system of a novel calcimimetic cinacalcet HCl using a porous carrier: In vitro and in vivo Characterisation. AAPS PharmSciTech 2019; 20(5): 216.
[http://dx.doi.org/10.1208/s12249-019-1411-2] [PMID: 31172322]
[51]
Abdelmonem R, Azer MS, Makky A, Zaghloul A, El-Nabarawi M, Nada A. Development, characterization, and in vivo pharmacokinetic study of lamotrigine solid self-nanoemulsifying drug delivery system. Drug Des Devel Ther 2020; 14: 4343-62.
[http://dx.doi.org/10.2147/DDDT.S263898] [PMID: 33116420]
[52]
Verma R, Mittal V, Kaushik D. Quality based design approach for improving oral bioavailability of valsartan loaded smedds and study of impact of lipolysis on the drug diffusion. Drug Deliv Lett 2018; 8(2): 130-9.
[http://dx.doi.org/10.2174/2210303108666180313141956]
[53]
Chalikwar SS, Surana SJ, Goyal SN, Chaturvedi KK, Dangre PV. Solid self-microemulsifying nutraceutical delivery system for hesperidin using quality by design: assessment of biopharmaceutical attributes and shelf-life. J Microencapsul 2021; 38(1): 61-79.
[http://dx.doi.org/10.1080/02652048.2020.1851788] [PMID: 33245007]
[54]
Sweed NM, Fayez AM, El-Emam SZ, Dawoud MHS. Response surface optimization of self nano-emulsifying drug delivery system of rosuvastatin calcium for hepatocellular carcinoma. J Pharm Investig 2020; 511(51): 85-101.
[http://dx.doi.org/10.1007/s40005-020-00497-6]
[55]
Verma R, Kaushik D. Design and optimization of candesartan loaded self-nanoemulsifying drug delivery system for improving its dissolution rate and pharmacodynamic potential. Drug Deliv 2020; 27(1): 756-71.
[http://dx.doi.org/10.1080/10717544.2020.1760961] [PMID: 32397771]
[56]
Kazi M, Alqahtani A, Ahmad A, et al. Development and optimization of sitagliptin and dapagliflozin loaded oral self-nanoemulsifying formulation against type 2 diabetes mellitus. Drug Deliv 2021; 28(1): 100-14.
[http://dx.doi.org/10.1080/10717544.2020.1859001] [PMID: 33345632]
[57]
Niu J, Xu Z, Li X, et al. Development and evaluation of rhubarb free anthraquinones loaded self-nanoemulsifying tablets. J Drug Deliv Sci Technol 2020; 57: 101737.
[http://dx.doi.org/10.1016/j.jddst.2020.101737]
[58]
Buya AB, Ucakar B, Beloqui A, Memvanga PB, Préat V. Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDSs) for senicapoc. Int J Pharm 2020; 580: 119180.
[http://dx.doi.org/10.1016/j.ijpharm.2020.119180] [PMID: 32135227]
[59]
Shailendrakumar AM, Ghate VM, Kinra M, Lewis SA. Improved oral pharmacokinetics of pentoxifylline with palm oil and Capmul® MCM containing self-nano-emulsifying drug delivery system. AAPS PharmSciTech 2020; 21(4): 118.
[http://dx.doi.org/10.1208/s12249-020-01644-w] [PMID: 32318890]
[60]
Beg S, Kaur R, Khurana RK, Rana V, Sharma T, Singh B. QbD-Based development of cationic self-nanoemulsifying drug delivery systems of paclitaxel with improved biopharmaceutical attributes. AAPS PharmSciTech 2019; 20(3): 118.
[http://dx.doi.org/10.1208/s12249-019-1319-x] [PMID: 30790136]
[61]
Rangaraj N, Shah S, A J M, et al. Quality by design approach for the development of self-emulsifying systems for oral delivery of Febuxostat: Pharmacokinetic and pharmacodynamic evaluation. AAPS PharmSciTech 2019; 20(7): 267.
[http://dx.doi.org/10.1208/s12249-019-1476-y] [PMID: 31346822]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy